Match tier
Listed
Presence
Formerly Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-16
S
Stephanie Rogers
Researcher
Formerly Arkansas Affiliated with UAMS through 2024.
Faculty Researcher
12 h-index
29 pubs
555 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Stephanie Rogers' research interests encompass multiple facets of health sciences, with a recent focus on the clinical management of adverse events associated with Talquetamab in patients diagnosed with relapsed or refractory Multiple Myeloma. Her work also addresses best practices for developing inpatient programs aimed at preventing falls in older adults after discharge. Rogers investigates the variability of Minimal Residual Disease (MRD) status and its impact on clinical outcomes in Multiple Myeloma, exploring its dependence on molecular subgroups defined by gene expression profiling. Her scholarship metrics include an h-index of 12, with 29 total publications and 550 total citations. She has collaborated with researchers such as Phillip Farmer, Hira Imad Cheema, Trilok Shrivastava, and Manozna Karri, all from the University of Arkansas for Medical Sciences, with whom she has shared one publication each.
Metrics
- h-index: 12
- Publications: 29
- Citations: 555
Selected Publications
-
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)
-
Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma (2024)
Collaboration Network
Top Collaborators
Donna Catamero
Mount Sinai Health System (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Chloe Ray
Mount Sinai Health System (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Kiah Purcell
Mount Sinai Health System (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Sheryl Leahey
City of Hope (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Elaine Esler
University of California, San Francisco (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Kayla Hefner
University of Arkansas for Medical Sciences
1 shared publication
In database
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Lisa O’Rourke
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Kathleen Gray
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Jaszianne Tolbert
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Thomas Renaud
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Saurabh Patel
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Linda Hannemann
Janssen (United States) (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Samantha Shenoy
University of California, San Francisco (US)
1 shared publication
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Sharmilan Thanendrarajan
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Phillip Farmer
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Similar Researchers
Based on overlapping research topics
Manuel Heredia
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Cancer Treatment and Pharmacology
Nishanth Thalambadu
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Health Sciences Research and Education
Cancer Treatment and Pharmacology
Christina Kincannon
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Health Sciences Research and Education
Cancer Treatment and Pharmacology
Jamie Ferguson
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Health Sciences Research and Education
Cancer Treatment and Pharmacology
Stefan Longobardi
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Health Sciences Research and Education
Cancer Treatment and Pharmacology
O. Makhoul
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Health Sciences Research and Education
Cancer Treatment and Pharmacology